Laboratorios Farmaceuticos Rovi, S.A.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
14.7 | 31.5 | -53.33% | 24.29 | -39.47% |
| P/S |
|
3.02 | 3.24 | -6.79% |
|
|
| P/BV |
|
5.09 | 3.36 | 51.65% |
|
|
| P/FCF |
|
0 | 21.26 | -100% |
|
|
| Ev/Ebitda |
|
10.35 | 9.95 | 3.99% |
|
|
| Ev/S |
|
3.06 | 1.89 | 61.94% |
|
|
| Ev/FCF |
|
43.76 | 19.94 | 119.48% |
|
|
| E/P |
|
0 | 1.47 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
29.61 | 24.35 | 21.63% | 26.86 | +10.26% |
| ROE |
|
34.92 | 13.19 | 164.71% |
|
|
| ROA |
|
23.55 | 6.14 | 283.67% |
|
|
| ROIC |
|
0 | 15.56 | -100% |
|
|
| ROS |
|
20.54 | 12.56 | 63.54% |
|
|
| ROCE |
|
45.01 | 14.36 | 213.52% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.1905 | 6.21 | -96.93% | 0.2479 | -23.13% |
| Nеt Debt/Ebitda |
|
0.1475 | -5.72 | -102.58% |
|
|
| Debt/Ratio |
|
0.0647 | 0.2122 | -69.52% |
|
|
| Debt/Equity |
|
0 | 12.49 | -100% |
|
|
| Debt/Net Income |
|
0.2747 | 15.05 | -98.18% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
9.9/10
|
3.96 | 1.72 | 129.74% | 1492.26 | -99.73% |
| Number of years of dividend growth |
|
1 | 1.27 | -21.11% | ||
| DSI |
|
0.9 | 0.7793 | 15.48% |
|
|
| Average dividend growth |
|
-68.47 | -270.17 | -74.66% |
|
|
| Average percentage for 5 years |
|
1492.26 | 2.79 | 53318.72% |
|
|
| Average percentage for payments |
|
33.68 | 246.79 | -86.35% |
|
|
| Difference from average difference in sector |
|
2.24 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
136.19 | 140.59 | -3.13% | ||
| Growth impulse Ebitda in 5 years |
|
337.35 | 107.17 | 214.78% | ||
| Growth impulse Net Income in 5 years |
|
370.53 | 123.16 | 200.85% | ||
| Growth impulse FCF in 5 years |
|
-227.14 | 93.68 | -342.46% | ||
| Growth impulse EPS in 5 years |
|
388.3 | 229.02 | 69.55% |
IP Score
7.45/10
